SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ind-Swift Laboratories informs about press release

22 Jan 2025 Evaluate
Ind-Swift Laboratories has informed that it enclosed copy of the advertisement for the Meetings of Equity Shareholders and Unsecured Creditors which is scheduled to be held on Saturday, 2204 February, 2025, pursuant to order dated 3 January, 2025 by Hon’ble National Company Law Tribunal (“NCLT”), Chandigarh Bench in the matter of the Scheme of Arrangement for Amalgamation between Ind-Swift (Transferor Company) and Ind-Swift Laboratories (Transferee Company), in Financial Express, Chandigarh edition in English language.

The above information is a part of company’s filings submitted to BSE.

Ind-Swift Lab. Share Price

144.45 0.00 (0.00%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1854.05
Dr. Reddys Lab 1313.40
Cipla 1374.00
Zydus Lifesciences 941.40
Lupin 2458.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×